Prof. Alberto Albanese

Sito Web

Pubblicazioni scientifiche

Articoli su riviste con fattore d'impatto
Volumi e audiovisivi
Capitoli in volumi

Articoli su riviste con fattore d'impatto

  1. Scoppetta C, Albanese A, Caltagirone C. Oligophrenia with the Hallermann-Streiff syndrome. Journal of Neurology 220: 211-214, 1979

  2. Albanese A, Butcher LL. Locus ceruleus somata contain both acetylcholinesterase and norepinephrine: direct histochemical demonstration on the same tissue section. Neuroscience Letters, 14: 101-104, 1979

  3. Albanese A, Butcher LL. Acetylcholinesterase and catecholamine distribution in the locus ceruleus of the rat. Brain Research Bulletin, 5: 127-134, 1980

  4. Amaducci L, Sorbi S, Albanese A, Gainotti G. Choline acetyltransferase (ChAT) activity differs in right and left human temporal lobes. Neurology, 31: 799-805, 1981

  5. Bentivoglio M, Macchi G, Albanese A. The cortical projections of the thalamic intralaminar nuclei, as studied in cat and rat with the multiple fluorescent retrograde tracer technique. Neuroscience Letters, 26: 5-10, 1981

  6. Albanese A, Bentivoglio M. The organization of dopaminergic and non-dopaminergic mesencephalo-cortical neurons in the rat. Brain Research, 238: 421-425, 1982

  7. Albanese A, Bentivoglio M. Retrograde fluorescent neuronal tracing combined with acetylcholinesterase histochemistry. Journal of Neuroscience Methods, 6: 121-127, 1982

  8. Di Trapani G, Pocchiari M, Masullo C, Albanese A, Tulli A. Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study. Italian Journal of Neurological Sciences, 3: 341-348, 1982

  9. Caltagirone C, Albanese A, Gainotti G, Masullo C. Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimer's presenile dementia. International. Journal of Neuroscience, 18: 143-147, 1983

  10. Albanese A, Minciacchi D. Organization of the ascending efferent projections from the ventral tegmental area: a multiple fluorescent retrograde tracer study in the rat. Journal of Comparative Neurology, 216: 406-420, 1983

  11. Albanese A, Altavista MC. Neuropeptides in dopamine-containing regions of the brain. Italian Journal of Neurological Sciences, 5: 391-404, 1984

  12. Albanese A, Castagna M, Altavista MC. Cholinergic and non-cholinergic forebrain projections to the interpeduncular nucleus. Brain Research, 329: 334-339, 1985

  13. Albanese A, Gozzo S, Iacopino C, Altavista MC. Strain-dependent variations in the number of forebrain cholinergic neurons. Brain Research, 334: 380-384, 1985

  14. Gozzo S, Iacopino C, Altavista MC, Albanese A. Histochemical demonstration of heavy metals in the reptilian archicortex. International Journal of Neuroscience, 28: 11-19, 1985

  15. Iacopino C, Altavista MC, Gozzo S, Albanese A. Quantitative pharmaco-histochemistry of acetylcholinesterase in neostriatum of inbred strains of mice. Brain Research, 374: 402-408, 1986

  16. Albanese A, Altavista MC, Rossi P. Organization of central nervous system dopaminergic pathways. Journal of Neural Transmission Supplement 22: 3-17, 1986

  17. Albanese A, Rossi P, Altavista MC. Can trazodone induce parkinsonism? Clinical Neuropharmacology, 11: 180-182, 1988

  18. Albanese A, Jenner P, Marsden CD, Stephenson JD. Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience Letters, 87: 46-50, 1988

  19. Altavista MC, Bentivoglio AR, Crociani P, Rossi P, Albanese A. Age-dependent loss of cholinergic neurones in basal ganglia of rats. Brain Research, 455: 177-181, 1988

  20. Willoughby J, Glover V, Sandler M, Albanese A, Jenner P, Marsden CD. Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity. Neuroscience Letters, 90: 100-106, 1988

  21. Ueki A, Chong PN, Albanese A, Rose S, Chivers JK, Jenner P, Marsden CD. Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin. Neuropharmacology, 28: 1089-1097, 1989

  22. Altavista MC, Rossi P, Bentivoglio AR, Crociani P, Albanese A. Aging is associated with a diffuse impairment of forebrain cholinergic neurons. Brain Research, 508: 51-59, 1990

  23. Albanese A, Altavista MC, Gozzo S, Rossi P, Colosimo C, Bentivoglio AR, Perretta G, Elia M, Monaco V, Macchi G. Chronic administration of MPTP to marmosets. Advances in Neurology, 53: 239-244, 1990

  24. Colosimo C, Rossi P, Elia M, Bentivoglio AR, Altavista MC, Albanese A. Transient alternating hemichorea as presenting sign of progressive supranuclear palsy. Italian Journal of Neurological Sciences, 12: 99-101, 1991

  25. Colosimo C, Granata R, Del Zompo M, Piccardi MP, Perretta G, Albanese A. Chronic administration of MPTP to monkeys: behavioural, morphological and biochemical correlates. Neurochemistry International, 20: 279S-285S, 1992

  26. Albanese A, Colosimo C, Carretta D, Dickmann A, Bentivoglio AR, Tonali P. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm. European Neurology, 32: 112-117, 1992

  27. Albanese A, Colosimo C, Bentivoglio AR, Bergonzi P. Unsuspected, surreptitious drug-induced parkinsonism. Neurology, 42: 459, 1992

  28. Del Zompo M, Piccardi MP, Ruiu S, Albanese A, M. Morelli. Localization of MPP+ binding sites in the brain of various mammalian species. Journal of Neural Transmission Parkinson's Disease and Dementia Section, 4: 181-190, 1992

  29. Albanese A, Daniele A, Lo Monaco M, Di Lazzaro V, Restuccia D, Milone M, Tonali P. Postural axial tremor in a patient with cerebellar atrophy. Movement Disorders, 7: 273-280, 1992

  30. Albanese A, Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetra¬hydro¬pyridine to monkeys: behavioural, morphological and biochemical correlates. Neuroscience, 55: 823-832, 1993

  31. Bentivoglio AR, Altavista MC, Granata R, Albanese A. Genetically determined cholinergic deficiency in the forebrain of C57BL/6 mice. Brain Research, 637: 181-189, 1994

  32. Colosimo C, Merello M, Albanese A. Clinical usefulness of apomorphine in movement disorders. Clinical Neuropharmacology, 17: 243-259, 1994

  33. Gui D, Cassetta E, Anastasio G, Bentivoglio AR, Maria G, Albanese A. Botulinum toxin for chronic anal fissure. Lancet, 344: 1127-1128, 1994

  34. Colosimo C, Albanese A, De Bruin V, Hughes AJ, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Archives of Neurology, 52: 294-298, 1995

  35. Colosimo C, Cassetta E, Bentivoglio AR, Albanese A. Clozapine in Huntington’s disease. Neurology, 45: 1023, 1995

  36. Albanese A, Colosimo C, Bentivoglio AR, Fenici R, Melillo G, Colosimo C, Tonali P. Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. Journal of Neurology, Neurosurgery & Psychiatry, 59: 144-151, 1995

  37. Colosimo C, Albanese A. Boxer disqualified for taking selegiline. Lancet, 346: 647, 1995

  38. Albanese A, Cassetta E, Carretta D, Bentivoglio AR, Tonali P. Acute challenge with apomorphine in Huntington’s disease: a double-blind study. Clinical Neuropharmacology, 18: 427-434, 1995

  39. Albanese A, Bentivoglio AR, Cassetta E, Viggiano A, Maria G, Gui D. The use of botulinum toxin on smooth muscles. European Journal of Neurology, 2: 29-33, 1995

  40. Albanese A, Bentivoglio AR, Cassetta E, Viggiano A, Maria G, Gui D. The use of botulinum toxin in the alimentary tract. Alimentary Pharmacology and Therapeutics, 9: 599-604, 1995

  41. Raja M, Altavista MC, Azzoni A, Albanese A. Severe barbiturate withdrawal syndrome in migrainous patients. Headache, 36: 119-121, 1996

  42. Albanese A, Bentivoglio AR, Colosimo C, Galardi G, Maderna L, Tonali P. Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. Journal of Neurology, Neurosurgery & Psychiatry, 60: 693-694, 1996

  43. Albanese A, Colosimo C, Lees AJ, Tonali P. The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism. Advances in Neurology 69: 393-398, 1996

  44. Raja M, Maisto G, Altavista MC, Albanese A. Tardive lingual dystonia treated with clozapine. Movement Disorders, 11: 585-586, 1996

  45. Albanese A, Colosimo C, Lees AJ. Multiple system atrophy. Archives of Neurology 53: 212-213, 1996

  46. Albanese A, Gregori B, Carretta D, Tonali P. Functional impairment of nigrostriatal neurones progresses following withdrawal of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience, 75: 1185-1191, 1996

  47. Daniele A, Bartolomeo P, Cassetta E, Bentivoglio AR, Gainotti G, Albanese A. Obsessive-compulsive behaviour and cognitive impairment in a parkinsonian patient following left putaminal lesion. Journal of Neurology Neurosurgery & Psychiatry, 62: 288-289, 1997

  48. Bentivoglio AR, Del Grosso N, Albanese A, Cassetta E, Tonali P, Frontali M. Non-DYT1 dystonia in a large Italian family. Journal of Neurology Neurosurgery & Psychiatry, 62: 357-360, 1997

  49. Daniele A, Albanese A, Gainotti G, Gregori B, Bartolomeo P. Zolpidem in Parkinson’s disease. Lancet, 349: 1222-1223, 1997

  50. Albanese A Emerging treatments in Parkinson’s disease. European Neurology, 38: 175-183, 1997

  51. Albanese A, Maria G, Bentivoglio AR, Brisinda G, Cassetta E, Tonali P. Botulinum toxin in the treatment of chronic constipation in Parkinson’s disease. European Journal of Neurology, 4 (Supplement 2): S81-S83, 1997

  52. Albanese A, Maria G, Bentivoglio AR, Brisinda G, Cassetta E, Tonali P Severe constipation in Parkinson's disease relieved by botulinum toxin. Movement Disorders, 12: 764-766, 1997

  53. Bentivoglio AR, Bressman SB, Cassetta E, Carretta D, Tonali P, Albanese A. Analysis of blink rate patterns in normal subjects. Movement Disorders, 12: 1028-1034, 1997

  54. Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline injections for treatment of chronic anal fissure. New England Journal of Medicine, 338: 217-220, 1998

  55. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. Consensus statement on the diagnosis of multiple system atrophy. Clinical Autonomic Research, 8: 359-362, 1998

  56. Defazio G, Berardelli A, Abbruzzese G, Lepore V, Coviello V, Acquistapace D, Capus L, Carella F, De Berardinis MT, Galardi G, Girlanda P, Maurri S, Albanese A, Bertolasi L, Liguori R, Rossi A, Santoro L, Tognoni G, Livrea P. Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group. Journal of Neurology, Neurosurgery & Psychiatry, 64: 25-32, 1998

  57. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. Consensus statement on the diagnosis of multiple system atrophy. Journal of the Autonomic Nervous System, 74: 189-192, 1998

  58. Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure. Long-term results after two different dose regimens. Annals of Surgery, 228: 664-669, 1998

  59. Albanese A. The current model of basal ganglia organization: a clinician’s view. Movement Disorders, 13: 980-981, 1998

  60. Maria G, Destito A, Lacquaniti S, Bentivoglio AR, Brisinda G, Albanese A. Relief by botulinum toxin of voiding dysfunction due to prostatitis. Lancet, 352: 625, 1998

  61. Gilman S, Low PA, Quinn N, Albanese A, Ben Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK. Consensus statement on the diagnosis of multiple system atrophy. Journal of the Neurological Sciences, 163: 94-98, 1999

  62. Moro E, Albanese A. Apomorphine and levodopa challenge in patients with a focal midbrain lesion. Movement Disorders, 14: 269-275, 1999

  63. Rossi P, Albanese A, Moro E, Genuardi M, Tonali P. Clinical genetic study of familial Parkinson’s disease in Italy. Advances in Neurology, 80: 181-186, 1999

  64. LeWitt PA, Albanese A. New delivery systems for antiparkinsonian drugs. Advances in Neurology, 80: 549-554, 1999

  65. Albanese A, Nordera GP, Caraceni T, Moro E. Long-term ventralis intermedius thalamic stimulation for parkinsonian tremor. Italian Registry for Neuromodulation in Movement Disorders. Advances in Neurology, 80: 631-634, 1999

  66. Moro E, Scerrati M, Romito LMA, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease. Neurology, 53: 85-90, 1999

  67. Defazio G, Berardelli A, Abbruzzese G, Coviello V, Carella F, De Berardinis T, Galardi G, Girlanda P, Maurri S, Mucchiur M, Albanese A, Basciani M, Bertolasi L, Liguori R, Tambasco N, Santoro L, Assennato G, Livrea P. Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group. Journal of Neurology, Neurosurgery & Psychiatry, 67: 613-619, 1999

  68. Ghika J, Ghika-Schmid F, Frankhauser H, Assal G, Vingerhoets F, Albanese A, Bogousslavsky J, Favre J. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. Journal of Neurosurgery, 91: 313-321, 1999

  69. Cassetta E, Del Grosso N, Bentivoglio AR, Valente EM, Frontali M, Albanese A. Italian family with cranial cervical dystonia: clinical and genetic study. Movement Disorders, 14: 820-825, 1999

  70. Jarman PR, Del Grosso N, Valente EM, Leube B, Cassetta E, Bentivoglio AR, Waddy HM, Uitti RJ, Maraganore DM, Albanese A, Frontali M, Auburger G, Bressman SB, Wood NW, Nygaard TG. Primary torsion dystonia: the search for genes is not over. Journal of Neurology Neurosurgery & Psychiatry, 67: 395-397, 1999

  71. Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. New England Journal of Medicine, 341: 65-69, 1999

  72. Bentivoglio AR, Albanese A. Botulinum toxin in motor disorders. Current Opinion in Neurology, 12: 447-456, 1999

  73. Koller WC, Pahwa R, Lyons KE, Albanese A. Surgical treatment of Parkinson’s disease. Journal of the Neurological Sciences, 167: 1-10, 1999

  74. Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, Marsden D, Melamed E, Michel PP, Mizuno Y, Obeso J, Oertel W, Olanow W, Poewe W, Pollak P, Tolosa E. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Movement Disorders, 14 : 911-913, 1999

  75. The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. Sex-related influences on the frequency and age of onset of primary dystonia. Neurology, 53: 1871-1873, 1999

  76. Guridi J, Rodriguez-Oroz MC, Lozano AM, Moro E, Albanese A, Nuttin B, Gybels J, Ramos E, Obeso JA. Targeting the basal ganglia for deep brain stimulation. Neurology, 55 (Suppl. 6): S21-S28, 2000

  77. Rossi P, Colosimo C, Moro E, Tonali P, Albanese A. Acute challenge with apomorphine and levodopa in parkinsonism. European Neurology, 43: 95-101, 2000

  78. Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Albanese. Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome. Diseases of the Colon and Rectum, 43: 376-380, 2000

  79. Albanese A, Bentivoglio AR, Del Grosso N, Cassetta E, Frontali M, Valente EM, Tonali P. Phenotype variability of dystonia in monozygotic twins. Journal of Neurology, 247: 148-150, 2000

  80. Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. American Journal of Surgery, 179: 46-50, 2000

  81. The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. Journal of Neurology, 247: 787-792, 2000

  82. Jahanshahi M, Ardouin CMA, Brown RG, Rothwell JC, Obeso J, Albanese A, Rodriguez-Oroz MC, Moro E, Benabid AL, Pollak P, Limousin-Dowsey P. The impact of deep brain stimulation on executive function in Parkinson’s disease. Brain, 123: 1142-1154, 2000

  83. Gui D, De Gaetano A, Spada PL, Viggiano A, Cassetta E, Albanese A. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Alimentary Pharmacology and Therapeutics, 14: 829-834, 2000

  84. Valente EM, Bentivoglio AR, Cassetta E, Dixon PH, Davis MB, Ferraris A, Ialongo T, Frontali M, Wood NW, Albanese A. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in an Italian family with cranial-cervical or upper limb onset. Annals of Neurology, 49: 362-366, 2001

  85. Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, Albanese A, Wood NW. Localization of a novel autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. American Journal of Human Genetics, 68: 895-900, 2001

  86. Albanese A, Bonuccelli U, Brefel C, Chaudhuri KR, Colosimo C, Eichhorn T, Melamed E, Pollak P, Van Laar T, Zappia M. Consensus statement on the role of acute dopaminergic challenge in Parkinson’s disease. Movement Disorders, 16: 197-201, 2001

  87. Albanese A. The current status and use of botulinum toxins. European Journal of Neurology, 8 (Suppl. 4): 3-7, 2001

  88. Priori A, Cinnante C, Genitrini S, Pesenti A, Tortora G, Bencini C, Barelli MV, Buonamici V, Carella F, Girotti F, Soliveri P, Magrini F, Morganti A, Albanese A, Broggi S, Scarlato G, Barbieri S. Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: preliminary physiological results. Neurological Sciences, 22: 85-86, 2001

  89. Valente EM, Bentivoglio AR, Cassetta E, Dixon PH, Davis MB, Ferraris A, Ialongo T, Frontali M, Wood NW, Albanese A. Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1p36 in an Italian family with cranial-cervical or upper limb onset. Neurological Sciences, 22: 95-96, 2001

  90. Maria G, Brisinda G, Bentivoglio AR, Albanese A, Sganga G, Castagneto M. Anterior rectocele due to obstructed defecation relieved by botulinum toxin. Surgery, 129: 524-529, 2001

  91. The deep-brain stimulation for Parkinson's disease study group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. New England Journal of Medicine, 345: 956-963, 2001

  92. Bentivoglio AR, Cortelli P, Valente EM, Ialongo T, Ferraris A, Elia A, Montagna P, Albanese A. Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Movement Disorders, 16: 999-1006, 2001

  93. Brisinda G, Maria G, Sganga G, Bentivoglio AR, Albanese A, Castagneto M. Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissure. Surgery, 131: 179-184, 2002

  94. Valente EM, Brancati F, Ferraris A, Graham EA, Davis MB, Breteler MM, Gasser T, Bonifati V, Bentivoglio AR, De Michele G, Durr A, Cortelli P, Wassilowsky D, Harhangi BS, Rawal N, Caputo V, Filla A, Meco G, Oostra BA, Brice A, Albanese A, Dallapiccola B, Wood NW. PARK6-linked parkinsonism occurs in several European families. Annals of Neurology, 51: 14-18, 2002

  95. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson’s disease. Neurology, 58: 1546-1550, 2002

  96. Bentivoglio AR, Loi M, Valente EM, Ialongo T, Tonali P, Albanese A. Phenotypic variability of DYT1-PTD: does the clinical spectrum include psychogenic dystonia? Movement Disorders, 17: 1058-1063, 2002

  97. Romito LM, Raja M, Daniele A, Contarino MF, Bentivoglio AR, Barbier A, Scerrati M, Albanese A. Transient mania with hypersexuality following surgery for high frequency stimulation of the subthalamic nucleus in Parkinson’s disease. Movement Disorders, 17: 1371-1374, 2002

  98. Soliveri P, Monza D, Piacentini S, Paridi D, Nespolo C, Gellera C, Mariotti C, Albanese A, Girotti F. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives. Neurological Sciences, 23 (Suppl. 2): S105-S106, 2002

  99. Albanese A Dystonia in parkinsonian syndromes. Advances in Neurology, 91: 351-360, 2002

  100. Khan NL, Valente EM, Bentivoglio AR, Wood NW, Albanese A, Brooks DJ, Piccini P. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study. Annals of Neurology, 52: 849-853, 2002

  101. Restuccia D, Valeriani M, Barba C, Le Pera D, Bentivoglio A, Albanese A, Rubino M, Tonali P. Abnormal gating of somatosensory inputs in essential tremor. Clinical Neurophysiology, 114: 120-129, 2003

  102. Daniele A, Albanese A, Romito LMA, Barbier A, Contarino MF, Gasparini F, Bentivoglio AR, Zinzi P. Cognitive and behavioural effects of chronic subthalamic nucleus stimulation in Parkinson’s disease. Journal of Neurology Neurosurgery & Psychiatry, 74: 175-182, 2003

  103. Brisinda G, Civello IM, Albanese A, Maria G. Gastrointestinal smooth muscles and sphincters spasms: treatment with botulinum neurotoxin. Current Medicinal Chemistry, 10: 603-623, 2003

  104. Carella F, Bressanelli M, Piacentini S, Soliveri P, Geminiani G, Monza D, Albanese A, Girotti F. A study of arm movements in Huntington's disease under visually controlled and blindfolded conditions. Neurological Sciences, 23: 287-293, 2003

  105. Albanese A, Colosimo C. Dihydroergocriptine in Parkinson’s disease: clinical efficacy and comparison with other dopamine agonists. Acta Neurologica Scandinavica, 107: 349-355, 2003

  106. Albanese A, Brisinda G, Bentivoglio AR, Maria G. Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. American Journal of Gastroenterology, 98: 1439-1440, 2003

  107. Broggi G, Franzini A, Marras C, Romito L, Albanese A. Surgery of Parkinson's disease: inclusion criteria and follow-up. Neurological Sciences, 24 (Suppl. 1): S38-S40, 2003

  108. Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. Urology, 62: 259-264, 2003

  109. Soliveri P, Rossi G, Monza D, Tagliavini F, Piacentini S, Albanese A, Bugiani O, Girotti F. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Archives of Neurology, 60: 1454-1456, 2003

  110. Albanese A. The clinical expression of primary dystonia. Journal of Neurology, 250: 1145-1151, 2003

  111. Brancati F; Valente EM; Castori M; Vanacore N; Sessa M; Galardi G; Berardelli A; Bentivoglio AR; Defazio G; Girlanda P; Abbruzzese G; Albanese A; Dallapiccola B. Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia. Journal of Neurology Neurosurgery and Psychiatry, 74: 665-666, 2003

  112. Bentivoglio AR, Elia A, Filippini G, Valente EM, Fasano A, Albanese A. Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. Advances in Neurology, 94: 171-178, 2004

  113. Bentivoglio AR, Ialongo T, Contarino MF, Valente EM, Albanese A. Phenotypic characterisation of DYT13 primary torsion distonia. Movement Disorders, 19: 200-206, 2004

  114. Brisinda G, Bentivoglio AR, Maria G, Albanese A. Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms. Movement Disorders, 19 (Suppl. 8): S146-S156, 2004

  115. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304: 1158-1160, 2004

  116. Rossi G, Gasparoli E, Pasquali C, Di Fede G, Testa D, Albanese A, Bracco F, Tagliavini F. Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene. Annals of Neurology, 55: 448, 2004

  117. Brisinda G, Albanese A, Cadeddu F, Bentivoglio AR, Mabisombi A, Marniga G, Maria G. Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs. Dysport" controlled trial. Alimentary Pharmacology and Therapeutics, 19: 695-701, 2004

  118. Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, Romito L, Albanese A, Dallapiccola B, Bentivoglio AR. PINK1 mutations are associated with sporadic early onset parkinsonism. Annals of Neurology, 56: 336-341, 2004

  119. Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R. Rivastigmine for dementia associated with Parkinson's disease. New England Journal of Medicine, 351: 2509-2518, 2004

  120. Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F. Levodopa in the treatment of Parkinson’s disease: current controversies. Movement Disorders, 19: 997-1005, 2004

  121. Marelli C, Piacentini S, Garavaglia B, Girotti F, Albanese A. Clinical and neuropsychological correlates in two brothers with pantothenate kinase-associated neurodegeneration. Movement Disorders, 20: 208-212, 2005

  122. Romito LMA, Contarino MF, Ghezzi D, Franzini A, Garavaglia B, Albanese A. High frequency stimulation of the subthalamic nucleus is efficacious in Parkin disease. Journal of Neurology, 252: 208-211, 2005

  123. Pellecchia MT, Valente EM, Cif L, Salvi S, Albanese A, Scarano V, Bonuccelli U, Bentivoglio AR, D'Amico A, Marelli C, Di Giorgio A, Coubes P, Barone P, Dallapiccola B. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology, 64: 1810-1812, 2005

  124. Albanese A, Valente EM, Romito L, Bellacchio E, Elia A, Dallapiccola B. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson’s disease. Neurology, 64: 1958-1960, 2005

  125. Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P, Brusa L, Bentivoglio AR, Bonuccelli U, Petrozzi L, Abbruzzese G, Marchese R, Cortelli P, Grimaldi D, Martinelli P, Ferrarese C, Garavaglia B, Carelli V, Torroni A, Albanese A, Zeviani M. Mitochondrial DNA haplogroup K is associated with lower risk of idiopathic adult-onset Parkinson’s disease in Italians. European Journal of Human Genetics, 13: 748-752, 2005

  126. Albanese A, Piacentini S, Romito LM, Leone M, Franzini A, Broggi G, Bussone G. Suicide after successful deep brain stimulation for movement disorders. Neurology, 65: 499-500, 2005

  127. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain, 128: 2240-2249, 2005

  128. Geser F, Seppi K, Stampfer-Kountchev M, Kollensperger M, Diem A, Ndayisaba J,P, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T, Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M, Ferreira J, Rosa M,M, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T, Mathias C,J, Fowler C, Wood N, Quinn N, Widner H, Nilsson C,F, Lindvall O, Schimke N, Eggert K,M, Oertel W, Del Sorbo F, Carella F, Albanese A, Pellecchia M,T, Barone P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, Poewe W, Wenning GK. The European Multiple System Atrophy-Study Group (EMSA-SG), Journal of Neural Transmission, 112: 1677-1686, 2005

  129. Albanese A, Barnes MP, Bhatia KP, Fernandez-Alvarez E, Filippini G, Gasser T, Krauss JK, Newton A, Rektor I, Savoiardo M, Valls-Solè J. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. European Journal of Neurology, 13; 493-444, 2006

  130. Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK. Health-related quality of life in multiple system atrophy. Movement Disorders, 21: 809-815, 2006

  131. Brisinda G, Maria G, Bentivoglio AR, Cadeddu F, Marniga G, Brandara F, Albanese A. Management of bladder, prostatic and pelvic floor disorders. Neurotoxicity Research, 9: 161-172, 2006

  132. Saint-Cyr JA, Albanese A. STN DBS in PD: selection criteria for surgery should include cognitive and psychiatric factors. Neurology, 66: 1799-1800, 2006

  133. Bentivoglio AR, Daniele A, Albanese A, Tonali PA, Fasano A. Analysis of blink rate in patients with blepharospasm. Movement Disorders, 21: 1225-1229, 2006

  134. Elia AE, Filippini G, Bentivoglio AR, Fasano A, Ialongo T, Albanese A. Onset and progression of primary torsion dystonia in sporadic and familial cases. European Journal of Neurology, 13: 1083-1088, 2006

  135. Marongiu R, Ghezzi D, Ialongo T, Soleti F, Elia A, Cavone S, Albanese A, Altavista MC, Barone P, Brusa L, Cortelli P, Petrozzi L, Scaglione C, Stanzione P, Tinazzi M, Zeviani M, Dallapiccola B, Bentivoglio AR, Valente EM, Garavaglia B. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease. Movement Disorders, 21: 1232-1235, 2006

  136. Fasano A, Nardocci N, Elia AE, Zorzi G, Bentivoglio AR, Albanese A. Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature. Movement Disorders, 21: 1411-1418, 2006

  137. Naumann M, Albanese A, Heinen F, Molenaers G, Relja M. Safety and efficacy of botulinum toxin type A following long-term use. European Journal of Neurology, 13 (Suppl 4): 35-40, 2006

  138. Köllensperger M, Stampfer-Kountchev M, Seppi K, Geser F, Frick C, Del Sorbo F, Albanese A, Gurevich T, Giladi N, Djaldetti R, Schrag A, Fowler C, Low PA, Mathias CJ, Poewe W, Wenning GK. Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment. European Journal of Neurology, 14: 66-72, 2007

  139. Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, Albanese A. Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. Journal of Neurology Neurosurgey and Psychiatry, 78: 248-252, 2007

  140. Romito LM, Franzini A, Perani D, Carella F, Marras C, Capus L, Garibotto V, Broggi G, Albanese A. Fixed dystonia unresponsive to pallidal stimulation improved by motor cortex stimulation. Neurology, 68: 875-876, 2007

  141. Del Sorbo F, Elia AE, De Joanna G, Romito L.M, Garavaglia B, Albanese A. Normal cardiovascular reflex testing in patients with parkin disease. Movement Disorders, 22: 528-532, 2007

  142. Albanese A. Can falls be prevented in Parkinson’s disease? Journal of Neurology Neurosurgey and Psychiatry, 78: 661, 2007

  143. Cordella R, Carella F, Leone M, Franzini A, Broggi G, Bussone G, Albanese A. Spontaneous neuronal activity of the posterior hypothalamus in trigeminal autonomic cephalalgias. Neurological Sciences, 28: 93-95, 2007

  144. Albanese A. Dystonia: clinical approach. Parkinsonism and Related Disorders, 13: S356-S361, 2007

  145. Piacentini S, Romito L, Franzini A, Granato A, Broggi G, Albanese A. Mood disorder following DBS of the left amygdaloid region in a dystonia patient with a dislodged electrode. Movement Disorders, 23: 147-150, 2008

  146. Fiorio M, Gambarin M, Defazio G, Valente EM, Stanzani C, Moretto G, Loi M, Soliveri P, Nardocci N, Albanese A, Fiaschi A, Tinazzi M. Impaired body movement representation in DYT1 mutation carriers. Clinical Neurophysiology, 119: 1864-1869, 2008

  147. Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Archives of Neurology, 65: 1191-1194, 2008

  148. Kollensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK. Red flags for multiple system atrophy. Movement Disorders, 23: 1093-1099, 2008

  149. Lalli S, Albanese A. Rivastigmine in Parkinson’s disease. Expert Review in Neurotherapeutics, 8: 1181-1188, 2008

  150. Pagni CA , Albanese A, Bentivoglio A, Broggi G, Canavero S, Cioni B, Rose MD, Simone CD, Franzini A, Lavano A, Landi A, Meglio M, Modugno M, Romanelli L, Romito LM, Sturiale C, Valzania F, Zeme S, Zenga F. Results by motor cortex stimulation in treatment of focal dystonia, Parkinson's disease and post-ictal spasticity. The experience of the Italian Study Group of the Italian Neurosurgical Society. Acta Neurochirurgica Supplement, 101: 13-21, 2008.

  151. Del Sorbo F., Albanese A. Levodopa-induced dyskinesias and their management. Journal of Neurology, 255 (Supplement 4): 32-41, 2008.

  152. Marongiu R, Ferraris A, Ialongo T, Cavone S, Soleti F, Michiorri S, Elia AE, Ghezzi D, Albanese A, Altavista MC, Antonini A, Barone P, Brusa L, Cortelli P, Goldwurm S, Martinelli P, Pellecchia MT, Pezzoli G, Scaglione C, Stanzione P, Tinazzi M, Garavaglia B, Dallapiccola B, Bentivoglio AR, Valente EM, and the Italian PD Study Group. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Human Mutation, 29: 565, 2008.

  153. Fiorio M, Valente EM, Gambarin M, Bentivoglio AR, Ialongo T, Albanese A, Barone P, Pellecchia MT, Brancati F, Moretto G, Fiaschi A, Tinazzi M. Subclinical sensory abnormalities in unaffected PINK1 heterozygotes. Journal of Neurology, 255: 1372-1377, 2008.

  154. Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo Fermo S, Albanese A. Outcome predictors, efficacy and safety of Botox and Dysport in the long term treatment of hemifacial spasm. European Journal of Neurology, 16: 392-398, 2009.

  155. Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo Fermo S, Albanese A. Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: same toxin, two drugs. Neurotoxicity Research, 15: 224-231, 2009.

  156. Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Movement Disorders, 24: 557-563, 2009.

  157. Elia AE, Filippini G, Calandrella D, Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review. Movement Disorders: 24, 801-812, 2009.

  158. Albanese A, Bigalke H, Foster K, Hallett M, Jankovic J, Montecucco C, Schiavo G. Foreword. Toxicon, 54: 549, 2009.

  159. Esquenazi A, Mayer NH, Elia AE, Albanese A. Botulinum toxin for the management of adult patients with upper motor neuron syndrome. Toxicon, 54: 634-638, 2009.

  160. Jankovic J, Albanese A, Hallett M. Unique properties of botulinum toxins. Toxicon, 54: 675, 2009.

  161. Albanese A. Discussion of unique properties of botulinum toxins. Toxicon, 54: 702-708, 2009.

  162. Albanese A, Lalli S. Is this dystonia? Movement Disorders, 24: 1725-1731, 2009.

  163. Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Osio M, Ciceri E, Albanese A., Bruzzone MG. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. American Journal of Neuroradiology, 30: 1222-1226, 2009.

  164. Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, Schnitzler A, Timmermann L, Gironell AA, Molet J, Pascual-Sedano B, Rehncrona S, Moro E, Lang AC, Lozano AM, Bentivoglio AR, Scerrati M, Contarino MF, Romito L, Janssens M, Agid Y. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Movement Disorders, 24: 1154-1161, 2009.

  165. Ferraris A, Ialongo T, Passali GC, Pellecchia MT, Brusa L, Baruffa M, Guidubaldi A, Plaudetti G, Albanese A, Barone P, Dallapiccola B, Valente EM, Bentivoglio AR. Olfactory dysfunction in parkinsonism caused by PINK1 mutations. Movement Disorders: 24: 2350-2357, 2009.

  166. Bonetti M, Barzaghi C, Brancati F, Ferraris A, Bellacchio E, Giovanetti A, Ialongo T, Zorzi G, Piano C, Petracca M, Albanese A, Nardocci N, Dallapiccola B, Bentivoglio A.R, Garavaglia B, Valente EM. Mutation screening of the DYT6/THAP1 gene in Italy. Movement Disorders, 24: 2424-2427, 2009.

  167. Moro E, Lozano A.M, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz M.I, Quinn N.P, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto JL, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojtecki L, Gironell A, Rodriguez-Oroz M.C, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Movement Disorders, 25: 578-586, 2010.

  168. Romito LM, Contarino FM, Albanese A. Transient gender-related effects in Parkinson's disease patients with subthalamic stimulation. Journal of Neurology, 257: 603-608, 2010.

  169. Lalli S, Albanese A. The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Movement Disorders, 25: 1619-1626, 2010.

  170. Elia AE, Lalli S, Albanese A. Differential diagnosis of dystonia. European Journal of Neurology, 17 (Suppl. 1): 1-8, 2010.

  171. Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A. Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain, 133: 2664-2676, 2010.

  172. Albanese A, Asmus F, Bhatia K, Elia A, Elibol B, Filippini G, Gasser T, Krauss J, Nardocci N, Newton A, Valls-Solé J. EFNS guidelines on diagnosis and treatment of primary dystonias. European Journal of Neurology, 18: 5-18, 2011.

  173. Albanese A. Terminology for preparations of botulinum neurotoxins: what a difference a name makes. JAMA Journal of the American Medical Association, 305: 89-90, 2011.

Ritorna su

Volumi e audiovisivi

  1. Albanese A. I gangli motori e i disturbi del movimento. Piccin, Padova, 495 pagine, 1991

  2. Albanese A, Bentivoglio AR, Tonali P. I disturbi del movimento. Poli, Milano, 1993. Volume di 71 pagine e videocassetta di 30 minuti

  3. Bentivoglio AR, Cassetta E, Albanese A, Tonali P. La tossina botulinica nel trattamento del blefarospasmo e dell’emispasmo facciale. Studio Armati & C, 1996. Videocassetta di 35 minuti.

  4. Albanese A, Lee J, Moore AP, Naumann M. The Movement Disorder Society guide to botulinum toxin injections, a cura di Moore AP. Movement Disorder Society, 2002. CD interattivo

Ritorna su

Capitoli in volumi

  1. Butcher LL, Woolf NJ, Albanese A, Butcher SH. Cholinergic-monoaminergic interactions in selected regions of the brain: histochemical and pharmacological analyses. Advances in Behavioral Biology, 25: 723-738, 1981

  2. Amaducci L, Bracco F, Sorbi S, Albanese A, Gainotti G. Right and left differ-ences of cholinergic system in the human temporal lobes. Excerpta Medica International Congress Series, 568: 289-297, 1981

  3. Gozzo S, Iacopino C, Altavista MC, Albanese A. Early senescence of forebrain cholinergic neurons: a genetic animal model. Symposia in Neuroscience, 3: 299-303, 1986

  4. Oliverio A, Albanese A, Altavista MC, Castellano C, Gozzo S, Macchi G. A genetic approach to cholinergic ontogeny in the mouse. Current Problems in Senile Dementias, 1: 555-560, 1986

  5. Albanese A, Gozzo S, Altavista MC, Iacopino C, Rossi P. Morphometric study of cholinergic neurons in inbred strains of mice: genetically determined early loss of cholinergic neurons as a model of central nervous system cholinergic failure. In: Cellular and Molecular Basis for Cholinergic Function, a cura di Dowdall MJ, Hawthorne JN. VCH, Weinheim (Germania), pp. 684-688, 1987

  6. Albanese A, Gozzo S, Altavista MC. Loss of forebrain cholinergic neurones induced by ageing and by genetic factors. Current Problems in Senile Dementias, 2: 49-54, 1988

  7. Albanese A. Extrapyramidal system and extrapyramidal disorders. In: Neuroscience across the centuries, a cura di Rose FC. Smith-Gordon and Company, Londra, pp. 97-109, 1989

  8. Albanese A, Altavista MC, Colosimo C, Bentivoglio AR, Rossi P, Macchi G. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to marmosets. Advances in Behavioral Biology, 39: 523-531, 1991

  9. Ghika J, Albanese A. Dyskinesias. In: Textbook of Neurology, a cura di Fisher M, Bogousslavsky J, Butterworth-Heinemann, Newton (USA), pp. 247-254, 1998

  10. Colosimo C, Albanese A. La apomorfina: una herramienta diagnóstica y terapéutica. In: Tratamiento de la Enfermedad de Parkinson, a cura di Merello M, Lees AJ. Talleres graficos de “La ley”, Buenos Aires (Argentina), pp. 99-116, 1999

  11. Valente EM, Albanese A. Autres troubles du mouvement héréditaires. In: Traité de Neurologie, a cura di Bogousslavsky J, Mas J-L, Léger JM. Doin éditeurs, Vélizy-Villacoublay (Francia), 2000

  12. Albanese A, Brisinda G, Mathias CJ The autonomic nervous system and gastrointestinal disorders. In: The autonomic nervous system. Part II. Dysfunctions, a cura di Vinken PJ, Bruyn GW. Handbook of Clinical Neurology, 75: 613-663, 2001

  13. Bentivoglio AR, Cassetta E, Albanese A. Distonia. In: La malattia di Parkinson e i disturbi del movimento, a cura di Colosimo C, CIC edizioni internazionali, Roma, pp. 293-323, 2001

  14. Brisinda G., Maria G., Bentivoglio A.R., Albanese A The role of botulinum toxin in gastrointestinal disorders. In: Scientific and therapeutic aspects of botulinum toxin, a cura di Brin MF, Jankovic J, Hallett M. Lippincott, Williams & Wilkins, Philadelphia (USA), pp. 269-285, 2002

  15. Albanese A, Solida A. Disturbi del movimento. In: Malattie del Sistema Nervoso del Prof. Giorgio Macchi, a cura di Minciacchi D, Granato A. Volume 10 della serie Trattato di Medicina Interna. Piccin, Padova, pp 571-611, 2004.

  16. Contarino MF, Albanese A. Medical and surgical treatment of dystonia. In Dystonia, Volume 3 della serie World Federation of Neurology Seminars in Clinical Neurology, a cura di Munsat TL. Demos, New York (USA), pp. 31-42, 2005

  17. Contarino MF, Albanese A. Hypersalivation. In: Clinical uses of botulinum toxins, a cura di Ward AB, Barnes MP, Cambridge University press, Cambridge (UK), pp. 201-228, 2007

  18. Albanese A, Bentivoglio AR. Botulinum toxin in movement disorders. In: Parkinson Disease and Movement Disorders, quinta edizione, a cura di Jankovic J, Tolosa E, pp. 605-619, 2007

  19. Elia AE, Bentivoglio AR, Valente EM, Albanese A. Other Primary Generalised Dystonias. In: Clinical Diagnosis and Management of Distonia, a cura di Warner T, Bressman S, Informa Healthcare, London, pp. 65-72, 2007

Ritorna su

Si ricorda di attenersi alla vigente normativa sul Diritto d'Autore (Legge n. 633 del 22/4/1941 e successive modifiche e integrazioni). I testi delle pubblicazioni vengono forniti a solo scopo di consultazione scientifica e sono protetti dalla possibilità di effettuare stampe cartacee. I video possono essere scaricati solo a scopo di studio e non possono essere divulgati in alcuna forma senza il permesso scritto dell'autore e dell'editore.